Fri, May 24, 2013, 9:49 AM EDT - U.S. Markets close in 6 hrs 11 mins
http://articles.latimes.com/keyword/neupogen-drugSeems like WE have the less toxic of the 2...
i taught this article was a joke by the fools pumping so they could sell to us chumps.http://caps.fool.com/Blogs/first-pick-in-2010-telk/326518
telintra will be bought out soon, not only AMGN in the race also several BIG PHARMA bidding in. Anyway TELINTRA shows the very strong TELIK pipeline potential
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235963/Slam dunk results in our favor in Neupogen vs Telintra trial. Amgen must be sickleing to get hold of it.All the neutrophia indication could be dominated by Telintra, MDS is a beginning. Know what you own.
If we are a little lucky here Amgen will buy us out for 300 mill. They have Neupogen yes, but Telintra is better at least in AML.
all dreams, better to bet on lotto!
Sentiment: Strong Sell